Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Meta-analysisof addition and subtraction of Liujunzi Decoction in the treatment of stable lung and spleen deficiency syndrome of chronic obstructive pulmonary disease
Hits 1267  Download times 692  Received:June 20, 2021  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2021.10.17
Key Words   Liujunzi Decoction;chronic obstructive pulmonary disease;stable period;lung and spleen deficiency syndrome;Meta-analysis
Author NameAffiliation
LI Guofeng Department of Respiratory Medicine of Tianjin Beichen Hosptial, Tianjin 300400, China 
LI Yi Department of Respiratory Medicine of Tianjin Beichen Hosptial, Tianjin 300400, China 
Abstract
    [Objective] To evaluate the efficacy and safety of addition and subtraction of Liujunzi Decoction in the treatment of stable lung and spleen deficiency syndrome in patients with chronic obstructive pulmonary disease. [Methods] Searching with PubMed, EMBASE, Cochrane Library, China knowledge Network, Wanfang, Weipu, China Biomedical Database, to collect the randomized controlled trial of addition and subtraction of Liujunzi Decoction in the treatment of stable lung and spleen deficiency syndrome of chronic obstructive pulmonary disease(COPD). Time was limited to the establishment of the database until March 2019 by RevMan 5.3. [Results] The total of 10 articles were included, including 870 patients. The results of Meta-analysis showed that the addition and subtraction of Liujunzi Decoction can improve the total effective rate[OR=3.10, 95%CI(2.13, 4.51), P<0.000 01], improve some pulmonary function indicators like FEV1[SMD=0.73, 95%CI (0.29, 1.18), P=0.001], FEV1/FVC[SMD=0.75, 95%CI (0.41, 1.09), P<0.000 1], however, the difference was not statistically significant in FVC[SMD=0.28, 95%CI (-0.24, 0.81), P=0.27]. It can improve some arterial blood gas analysis indicators like SaO2[SMD=0.94, 95%CI(0.21, 1.67), P=0.01], PaCO2[SMD=-1.71, 95%CI(-2.02, -1.40), P<0.000 01]), but the difference of PaO2[SMD=2.71, 95%CI(-0.44, 5.86), P=0.09] had no statistical significance. It can improve TCM syndrome scores (Cough[SMD=-1.16, 95%CI(-1.76, -0.55), P=0.000 2], expectoration[SMD=-0.80, 95%CI(-1.48, -0.13), P=0.02], short breath[SMD=-0.43, 95%CI (-0.71, -0.14), P=0.003], eat less[SMD=-1.00, 95%CI (-1.30, -0.70), P<0.000 01], abdominal distension[SMD=-1.09, 95%CI(-1.39, -0.79), P<0.000 01]). It can improve exercise endurance[SMD=0.94, 95%CI (0.10, 1.77), P=0.03], improve MMRC[SMD=-0.58, 95%CI(-0.82, -0.34), P<0.000 01]. There was no significant statistical difference in BMI between the two groups[SMD=-0.41, 95%CI(-1.37, 0.55), P=0.41]. [Conclusion] Addition and subtraction of Liujunzi Decoction has curative and effective advantages in the treatment of stable lung and spleen deficiency syndrome of chronic obstructive pulmonary disease.

You are the Guest visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.